This page has been archived on the Web

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.

Archived

This page has been archived on the Web.

Health product recall

Durazest (2016-02-05)

Starting date:
February 5, 2016
Posting date:
February 16, 2016
Type of communication:
Drug Recall
Subcategory:
Natural health products
Hazard classification:
Type I
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-57076

Affected products

Durazest

Reason

Durazest capsule lots recalled as a precautionary measure.  Product used the same capsule shells found to be adulterated with Tadalafil in Forta for Men.

Depth of distribution

Retailers across Canada

Affected products

Durazest

DIN, NPN, DIN-HIM
NPN 80033381
Dosage form

Capsule

Strength
  • Ginkgo biloba 50.0 mg
  • Epimedium brevicornu 150.0 mg
  • Lycium barbarum 80.0 mg
  • Ophiocordyceps sinensis 120.0 mg
  • Panax ginseng 100.0 mg
Lot or serial number
  • Lot 230
  • Lot 231
  • Lot 232
  • Lot 233
Companies
Recalling Firm
Vivo Brand Management
3318 Second Street East
Cornwall
K6H 6J8
CANADA
Marketing Authorization Holder
Vivo Brand Management
3318 Second Street East
Cornwall
K6H 6J8
CANADA

Date modified: